Neurostimulation Devices Market Revenue at CAGR of ~19.5%Forecasts by 2022A Story by sumit choudhari Neurostimulation Devices Market report is an expert analysis report which gives detail information about industry players, segmentation and regional data in-depth. Neurostimulation is a
modulation of the nervous system’s activity. It is deliberately carried out by
using invasive and non-invasive techniques. Implantable stimulation devices are
most commonly used in the treatment of the neurological conditions such as
epilepsy, Parkinson’s disease, dystonia, tremors, depression, obsessive
compulsive disorder, diabetic neuropathy, and few other conditions. Increasing
cases of the neurological disorders such as chronic pain and depression high
adoption of the neurostimulation therapy are likely to improve the market of
neurostimulation devices. According to the World
Health Organisation (WHO) neurological disorders are responsible for 4.5%-11%
of all illnesses including in low or high income economies. This is far higher
as compared to the number of respiratory ailments, gastrointestinal disorders,
or cancers, and the burden is expected to rise further over the coming years.
Intended
Audience · Neurostimulation
devices manufacturers and suppliers ·
Contract research
organizations (CROs) ·
Research and
development (R&D) companies ·
Government &
independent research laboratories ·
Government and
independent regulatory authorities ·
Market research and
consulting service providers ·
Academic institutes
and universities Neurostimulation
Devices Market Segmentation: Neurostimulation
devices market has been segmented on the basis of type which comprises
implantable devices, and external devices. Implantable devices include deep
brain stimulators, spinal cord stimulators, sacral nerve stimulators, gastric
electric stimulators, cochlear implants, and vagus nerve stimulators; whereas
external devices include transcutaneous electrical nerve stimulator, and
transcranial magnetic stimulator. On the basis of application, the market is
segmented into dystonia, epilepsy, Parkinson's disease, depression,
gastroparesis, pain management, tremors, urinary and fecal incontinence, and
others. On the basis of end user, market is segmented into hospitals/clinics,
cognitive care centers, research institutes and others. Key Players Some of the key players in this market
are: Autonomic Technologies, Boston Scientific, ElectroCore, ImThera Medical,
Inspire Medical Systems, LivaNova (Cyberonics), Medtronic, NeuroMetrix,
NeuroPace, Neuros Medical, NeuroSigma, Nevro Corporation, SPR Therapeutics,
St.Jude Medical, Synapse Biomedical, and others. Regional Analysis America account for the
largest market share in neurostimulation devices market. The growth is
attributed to an increasing demand for cardiovascular devices for the treatment
of cardiovascular diseases and increasing prevalence of neurological diseases
in the market. Additionally, the market growth is also boosted by increasing
expenditure on neurostimulation devices in North America. Additionally, invention of
new technology, increasing awareness, and investments in research and
development have boosted the neurostimulation market. However, high cost
associated with monitoring and diagnosis of disease may restrain the market
growth. According to Centre for
Disease Control and Prevention (CDC), in 2015, 1.2% of the total U.S.
population had active epilepsy accounting for about 3.4 million people with
epilepsy nationwide which includes 3 million adults and 470,000 children. The
total indirect and direct cost of epilepsy in the U.S. is estimated to be USD
15.5 billion yearly. Huge number of patients suffer with other neurological
disorders. Additionally, rising
geriatric population across the globe also fuels the growth of the market.
According to World Population Ageing Report, in 2017, there are an estimated
962 million people aged 60 or over globally, which is 13% of the total global
population. According to the population reference bureau, the number of Americans
ageing 65 and older is projected to more than double from 46 million in 2015 to
over 98 million by 2060. According to the StastsCan, 2015, over 5.7 million
Canadians have aged 65 and older, which was 16.1 % of Canadian population. Table Of Content 1 INTRODUCTION 1.1 DEFINITION 1.2 SCOPE OF STUDY 1.2.1 RESEARCH OBJECTIVE 1.2.2 ASSUMPTIONS &
LIMITATIONS 1.2.2.1 ASSUMPTIONS 1.2.2.2 LIMITATIONS 1.3 MARKET STRUCTURE 2 RESEARCH METHODOLOGY 2.1 RESEARCH PROCESS: 2.2 PRIMARY RESEARCH 2.3 SECONDARY RESEARCH 3 MARKET DYNAMICS 3.1 DRIVERS 3.2 RESTRAINTS 3.3 OPPORTUNITIES 3.4 MACROECONOMIC
INDICATORS 4 MARKET FACTOR ANALYSIS 4.1 PORTERS FIVE FORCES
MODEL 4.2 BARGAINING POWER OF
SUPPLIERS 4.3 BARGAINING POWER OF
BUYERS 4.4 THREAT OF NEW ENTRANTS 4.5 THREAT OF SUBSTITUTES 4.6 INTENSITY OF RIVALRY TOC Continued….! © 2018 sumit choudhariAuthor's Note
|
StatsAuthor
|
Share This
Email
Facebook
Twitter
Read Request
My Library
Subscribe
Flag Writing
